Although caveolin-1 is thought to facilitate the interaction of receptors and signaling components, its role in epidermal growth factor receptor (EGFR) signaling remains poorly understood.
Introduction
The plasma membrane of eukaryotic cells is not uniform, but instead is comprised of microdomains or rafts, highly dynamic lateral assemblies composed of glycosphingolipids and cholesterol. One form of these rafts, caveolae, has been distinguished ultrastructurally by its invaginated shape and by the presence of caveolin-1, the major structural protein of caveolae.
These caveolin-containing rafts are insoluble in both nonionic detergents, such as Triton X-100, and in sodium carbonate at alkaline pH, and can be isolated as low-density fractions by sucrose density gradient. Although caveolae have been implicated as sites at which receptors and signaling molecules interact (1, 2) , signaling also occurs at non-invaginated rafts, devoid of caveolin-1 but enriched in glycosphingolipids (3) (4) (5) . In addition, caveolin-1 may also exist in lipid rafts without caveolae (6) . The distinction between lipid rafts and caveolae, and the attribution of specific biologic functions and signaling pathways to one or the other remains confusing in the literature (7) .
Caveolae have been proposed to be the site of epidermal growth factor receptor (EGFR) GM3 modulates caveolin-1/EGFR interaction 4 insoluble membrane (12) . Immunoelectron microscopy localization studies show only a small proportion of the EGFR in caveolae (13) , further suggesting that EGFR is largely localized in noncaveolar membrane domains.
Yet, the evidence for an interaction between caveolin-1 and the EGFR that suppresses EGFR activation is strong. Depletion of caveolin-1 has been associated with tumor proliferation (14) , psoriasis, a hyperproliferative skin disorder, and stimulation of mitogen activated protein kinase signaling (15) . In addition, re-expression of caveolin-1 in oncogenically transformed cells and in human breast cancer cells inhibits cell growth (16, 17) . The "scaffolding domain" of caveolin-1 has been shown to co-immunoprecipitate with and bind directly to the binding sequence motifs in the kinase domain of the EGFR (10, 18) . A regulatory role of caveolin-1 in EGFR signaling is further suggested by the suppression of cell proliferation and EGF-induced migration when caveolin-1 binds to the EGFR (19) . These studies suggest a role for caveolin-1 in maintaining the EGFR in an inactive state, with dissociation from caveolin-1 promoting EGFR activation.
The role of phosphorylation of caveolin-1 in EGFR signaling is unknown. EGF is able to tyrosine phosphorylate caveolin-1 in A-431 cells (20) , although not in adipocytes (20) or fibroblasts (21) .
The effect of this tyrosine phosphorylation of caveolin-1 on EGFR activity, however, is controversial (20) , and the effect of ganglioside on caveolin-1 tyrosine phosphorylation has not been explored. Caveolin-1 also has 12 putative sites for serine phosphorylation that are highly conserved (22) . Of these sites, only mutation at Ser 80 blocks its serine phosphorylation.
Schlegel et al. have recently suggested that the phosphorylation site at Ser 80 is required for endoplasmic reticulum retention and caveolin-1 secretion, and for homo-oligomerization (22) ; other roles for serine phosphorylation of caveolin-1, including in signaling, have not been determined.
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Gangliosides are sialylated membrane glycosphingolipids that modulate several biologic processes of keratinocytes and keratinocyte-derived cell lines in vitro, including cell proliferation, adhesion, migration, differentiation, and apoptosis, at least in part by affecting transmembrane signaling (23) (24) (25) (26) (27) (28) (29) . Studies from our laboratory and others have shown that GM3, the predominant ganglioside of the membranes of both normal cultured keratinocytes and the keratinocyte-derived SCC12 cell line (26, 30) , inhibits cell proliferation by suppressing EGFR activation (31) and downstream signaling (26) . The mechanism for this ganglioside-specific inhibition appears to involve both binding of GM3 directly to the EGFR that requires receptor glycosylation (28) and direct post-binding effects on signal transduction (26, 28) . Consistently, endogenous depletion of gangliosides, including GM3, by stable transfection of SCC12 cells with sialidase cDNA leads to cell hyperproliferation and stimulation of EGFR signaling, especially in response to EGFR ligands (26) . Although ganglioside GM1 is considered a marker for caveolae (32) (33) (34) (35) , and GD3 (36) also likely localizes to caveolar domains, GM3 has been localized predominantly to carbonate-and detergent-insoluble low-density "glycosphingolipid-rich membrane" regions (4) . Its relationship with caveolin-1 is unclear (5, (37) (38) (39) (40) .
Taking advantage of the distinct localizations of EGFR and caveolin-1 after detergent separation of membrane domains, we investigated the effects of endogenous modulation of ganglioside GM3 expression on caveolin-1 distribution, phosphorylation, and interaction with the EGFR.
Our studies show that endogenous overexpression of GM3 promotes transport of caveolin-1 from the Triton X-100 insoluble, low-density membrane regions to the soluble, high-density domains in which EGFR predominates. GM3 overexpression increases both the association of caveolin-1 with EGFR and the tyrosine phosphorylation of caveolin-1, which may contribute to suppression of both EGFR dimerization and autophosphorylation. GM3 also induces the later phosphorylation of serine residues on caveolin-1 that is unassociated with EGFR. These results suggest a possible mechanism by which GM3 regulates the suppression of EGFR activation. 
Experimental Procedures
Cells----Human keratinocyte-derived cell line SCC12F2 cells, a generous gift from Dr. James Rheinwald, Boston, MA, were maintained in Dulbecco's Modified Eagle's Medium /F12 (DMEM/F12) (Life Technologies) (1:1) medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) without antibiotics in 5% CO 2 at 37 o C.
Overexpression of GM3 by Treatment with Antisense Oligodeoxynucleotides----To endogenously
increase the membrane content of GM3 on SCC12 cells, SCC12 cells were pretreated with antisense oligodeoxynucleotides of both GM2/GD2 synthase and GD3 synthase, leading to blockade of synthetic pathways downstream of GM3 (Fig. 1A) . The synthetic oligodeoxynucleotides were generated complementary to either the sense or the antisense strand of the 21 nucleotides at the 5' end encoding human GM2/GD2 synthase or GD3 synthase (41), including the initiator codon ATG. These included 5'-GACAGGATGTGGCTGGGCCGC- plates, grown for 6-8 h, then fixed for ganglioside detection as described below in the legend for Figure 2 . and then 50% protein A:agarose (Transduction Labs) was added as previously described (27) .
Effect of Endogenous GM3 Expression on Dimerization of the EGFR----To
Immunoblotting----Immunoblotting was carried out as described (27) GM3 modulates caveolin-1/EGFR interaction 9 detected using enhanced chemiluminscence and band density was analyzed by the Storm 800
PhosphorImager. 
Statistics----Quantitative

Results
Endogenous Overexpression of GM3 by Antisense Treatment Leads to GM3 Clustering in Both
Cytoplasm and on the Membrane----TLC immunostaining and ganglioside ELISA were employed to detect ganglioside expression after SCC12 cells were treated with or without sense or antisense oligodeoxynucleotides of both GM2/GD2 synthase and GD3 synthase. 3A, bottom row, lane 3; B, lane 2). GM3 accumulation had no effect on EGFR expression (Fig.   3A , top row).
Endogenous Overexpression of GM3 Facilitates the Interaction of GM3 and Caveolin-1 with EGFR----Immunoprecipitation of membrane EGFR from whole cell lysates with GM3
overexpression showed a doubling of caveolin-1 (p<0.01) (Fig. 4, Triton X-100 soluble membrane microdomains (Fig. 5B , C, top rows) and the alteration of GM3 expression had no effect on either the expression (not shown) or distribution of the EGFR (Fig.   5B , top row, lanes 3, 4, 7, 8; C, top row). In contrast, caveolin-1 shifted from the Triton X-100 insoluble membrane microdomains into soluble membrane microdomains that contained the EGFR when GM3 was overexpressed (Fig. 5B, middle row, lanes 3, 7) . Consistently, endogenous ganglioside depletion by treatment with PPPP ( (Fig. 6A, 4th row, lanes 5,6) . Concurrently, overexpression of GM3 inhibited the autophosphorylation of EGFR by 4.1-fold (Fig. 6A, 2nd row, lane 7) in comparison with untreated or sense oligomer-treated cells (p<0.001) (Fig. 6A, 2nd row, lanes 5, 6) after stimulated with either 10 nM EGF or 12 nM TGF-(not shown). Ligand stimulation had no effect on the sustained GM3-induced doubling of the amount of caveolin-1 associated with EGFR (Fig. 6A,   3rd row, lanes 4, 7, 10, 13). However, without exposure to EGF, caveolin-1 was not tyrosine phosphorylated, regardless of the increase in GM3 (Fig. 6A, 4th row, lane 4). When ganglioside was depleted by sialidase overexpression (Fig. 6B, 4th row, lanes 7, 10, 13) or PPPP treatment p<0.001). Endogenous overexpression of GM3 had no effect on the weak tyrosine phosphorylation of caveolin-1 unassociated with the EGFR (Fig. 7A, middle row) . Consistently, decreasing GM3 expression also had no effect on the weak tyrosine phosphorylation of caveolin-1 that was not associated with the EGFR (Fig. 7B, middle row) .
The effect of ganglioside GM3 on serine phosphorylation of caveolin-1 was also determined using immunoblotting. Caveolin-1 in association with the immunoprecipitated EGFR was never serine phosphorylated, regardless of GM3 content (Fig. 6A, B, bottom rows) . However, and 60 min after starving of both serum and growth factors. After immunoprecipitation of EGFR, the remaining cell lysate was incubated with polyclonal anti-caveolin-1 antibody to by guest on November 19, 2017 
